Difference between revisions of "Minutes - Medication WG 2021-06-08"

From Health Level 7 Belgium Wiki
Line 49: Line 49:
 
::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
 
::::* different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
  
 
+
* During the workshop 12 scenario's have been defined:
* 12 scenario's have been defined
 
 
::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster
 
::* Prescribed branded medication is changed by another branded medication from the same VOS-cluster
 
::* Prescribed medication is changed by another medication from a different VOS-cluster
 
::* Prescribed medication is changed by another medication from a different VOS-cluster
Line 79: Line 78:
 
::::* patient is admitted, hospital takes over the medication from the scheme
 
::::* patient is admitted, hospital takes over the medication from the scheme
 
::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme
 
::::* patient is discharged, hospital reconciles the medication that was used with the medication scheme
 +
 +
* Do we have to extend the model to include individual prescriptions ?
 +
::* is the posology already sufficient as it is now in the model ?
 +
::* the regimen exists today and the model should foresee something similar
 +
::* for the pharmacist the time b/w the different intakes and with or without food is important
  
 
'''Action items for next meeting'''
 
'''Action items for next meeting'''

Revision as of 09:37, 8 June 2021

Attendees
  • Anne Nerenhausen
  • Annemieke Vergauwe
  • Bruno Casneuf
  • Elhassan Baazizi
  • Jean-Michel Polfliet
  • José Costa Teixeira
  • Katrien Thorré
  • Karlien Erauw
  • Nick Hermans
  • Pablo Christiaens
  • Richard Francken
  • Robin Bosman
  • Thomas Van Langendonck
  • Tom De Backer
  • Tom Henkens
Excused/Not present
  • Dieter Sauvillers
  • Hanne Vuegen
  • Jan Lenie
  • Jean-Louis Maggetto
  • Jens Penny
  • Jeroen De Wilde
  • Lars Vanreppelen
  • Marc Buckens
  • Nils Devos
  • Richard Francken
  • Will van Norel
Agenda
  • review of SAMv1 to SAMv2 mapping
  • review of the examples
Minutes
  • please collect feedback in your team and send it by email to Karlien
  • feedback on the FHIR medication workshop that took place with a couple of WG-members last week
  • “Stofnaam” aka “Substance” should be changed by VOS-cluster. Under a VOS-cluster we understand the following:
  • Same substance(s)
  • Same strength
  • Comparable package size
  • Form of administration
  • Additional info:
  • to check: Contramal 100 mg vs Contramal 100 mg retard
  • comparable package sizes are not packaged in Belgium (was under discussion once)
  • different VMP's are grouped in a cluster code, same administration code, not form of administration (disrriminiation of syrop vs pills is done through strength)
  • During the workshop 12 scenario's have been defined:
  • Prescribed branded medication is changed by another branded medication from the same VOS-cluster
  • Prescribed medication is changed by another medication from a different VOS-cluster
  • Different strength, different package size or different form of administration is dispensed
  • Different substance(s) is dispensed
  • Dispense medication before the prescription of the general practitioner
  • e.g. stomach protector that is delivered to the patient
  • Dispense of prescribed medication, and dispense of a product that can be done without a prescription
  • Dispense of new brand medication that is given because the old is unavailable, so giving to continu the cure and not to replace it
  • Refuse the dispense prescribed medication
  • Dispense of medication that was prescribed, but not taken
  • e.g. an antibiotic that is prescribed when doing international travel as a safeguard
  • Dispense of medication that was prescribed, but not taken till the end
  • e.g. an antibiotic that is prescribed but when using the patient had an allergic reaction
  • might be connected to scenario 3, when the pharmacist gives an alternative
  • The recording of anesthetic, contrast and similar medications in the medication scheme
  • The recording of non-medication aka pharmaceutical products
  • Food supplement
  • Sunscreen
  • ...
  • The view and/or filters for
  • a GP
  • a nurse / caretaker
  • a pharmacist
  • a specialist
  • a patient
  • The patient is admitted to hospital and there the medication is changed to better help the patient.
  • patient is admitted, hospital takes over the medication from the scheme
  • patient is discharged, hospital reconciles the medication that was used with the medication scheme
  • Do we have to extend the model to include individual prescriptions ?
  • is the posology already sufficient as it is now in the model ?
  • the regimen exists today and the model should foresee something similar
  • for the pharmacist the time b/w the different intakes and with or without food is important

Action items for next meeting

  • review of the examples

Next meeting June 22 at 11AM